Literature DB >> 19652403

Structure-analgesic activity relationship studies on the C(18)- and C(19)-diterpenoid alkaloids.

Jian-Li Wang1, Xiang-Li Shen, Qiao-Hong Chen, Gong Qi, Wei Wang, Feng-Peng Wang.   

Abstract

For evaluation of C(18)- and C(19)-diterpenoid alkaloids as analgesics, three C(19)-diterpenoid alkaloids were isolated from the roots of Aconitum hemsleyanum var. circinatum and A. transsecutum; and twenty-five semisynthetic C(18)- or C(19)-diterpenoid alkaloids were prepared from lappaconitine, crassicauline A or yunaconitine. In a mice acetic acid-induced abdominal constriction assay, four crassicauline A analogs and three yunaconitine analogs exhibited good analgesic activities with 77.8-94.1% inhibition range in 0.1-10 mg/kg subcutaneous (s.c.) dose range at the point of 20 min after drug administration. Among them, 8-O-deacetyl-8-O-ethylcrassicauline A (ED(50)=0.0972 mg/kg) and 8-O-ethylyunaconitine (ED(50)=0.0591 mg/kg) were the most potent analgesics relative to the reference drugs lappaconitine (ED(50)=3.50 mg/kg) and crassicauline A (ED(50)=0.0480 mg/kg). Analgesic activity data of these C(18)- and C(19)-diterpenoid alkaloids indicate that a tertiary amine in ring A, an acetoxyl or an ethoxyl group at C-8, an aromatic ester at C-14, and the saturation state of the ring D are important structural features necessary to the analgesic activity of the C(19)-diterpenoid alkaloids.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19652403     DOI: 10.1248/cpb.57.801

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  7 in total

1.  Hydroxylation Metabolisms of Crassicauline A in Rats Under Toxic Dose.

Authors:  Xue Fan; Shan-Shan Yin; Xue-Jing Li; Kui Yang; Liang Xu; Ke Lan
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-10       Impact factor: 2.441

2.  Lappaconitine, a C18-diterpenoid alkaloid, exhibits antihypersensitivity in chronic pain through stimulation of spinal dynorphin A expression.

Authors:  Ming-Li Sun; Jun-Ping Ao; Yi-Rui Wang; Qian Huang; Teng-Fei Li; Xin-Yan Li; Yong-Xiang Wang
Journal:  Psychopharmacology (Berl)       Date:  2018-06-20       Impact factor: 4.530

3.  New norditerpenoid alkaloids from Aconitum vilmorinianum Komarov.

Authors:  Cui-Ling Chen; Wen-Hong Tan; Yan Wang; Zhi-Ge Xue; Chun-Ping Wan; Zhu-Ya Yang; Zhi-Hong Zhou; Xiao-Xia Ma
Journal:  J Nat Med       Date:  2015-07-01       Impact factor: 2.343

4.  An Investigation on the Quantitative Structure-Activity Relationships of the Anti-Inflammatory Activity of Diterpenoid Alkaloids.

Authors:  Xiao Li; Ning Li; Zhenyu Sui; Kaishun Bi; Zuojing Li
Journal:  Molecules       Date:  2017-02-27       Impact factor: 4.411

5.  Synthesis, in vitro and in vivo biological evaluation of novel lappaconitine derivatives as potential anti-inflammatory agents.

Authors:  Lei Pang; Chun-Yan Liu; Guo-Hua Gong; Zhe-Shan Quan
Journal:  Acta Pharm Sin B       Date:  2019-09-13       Impact factor: 11.413

Review 6.  C18-diterpenoid alkaloids in tribe Delphineae (Ranunculaceae): phytochemistry, chemotaxonomy, and bioactivities.

Authors:  Yuanfeng Yan; Xing Li; Ze Wang; Xiaoyan Yang; Tianpeng Yin
Journal:  RSC Adv       Date:  2021-12-22       Impact factor: 3.361

7.  Analgesic Activity, Chemical Profiling and Computational Study on Chrysopogon aciculatus.

Authors:  S M Neamul Kabir Zihad; Niloy Bhowmick; Shaikh Jamal Uddin; Nazifa Sifat; Md Shamim Rahman; Razina Rouf; Muhammad Torequl Islam; Shrabanti Dev; Hazrina Hazni; Shahin Aziz; Eunüs S Ali; Asish K Das; Jamil A Shilpi; Lutfun Nahar; Satyajit D Sarker
Journal:  Front Pharmacol       Date:  2018-10-15       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.